User: prashantiyengar Topic: IP
Category: drugs :: india
Last updated: Apr 27 2017 23:46 IST RSS 2.0
 
1 to 20 of 2,776    
Working to cut patent examination time to 18 months: Nirmala Sitharaman 27.4.2017 ET: Policy
The ministry is continuously working on simplification of rules and reducing the patent examination time, Commerce and Industry Minister Nirmala Sitharaman said.
Also found in: [+]
Prescribing generic medicines already a must under MCI rules 19.4.2017 TOI: India
While PM Modi has said that “legal arrangements“ will be made to make prescription of generic medicines compulsory, the fact is that this is already mandatory . The Medical Council of India's ethics code for docs made generic prescription mandatory in October 2016, though it has never been enforced.
Also found in: [+]
PM's push for generic drugs to shift focus to chemists, says pharma industry body 18.4.2017 ET: Pharma
Patients may end up with drugs that "may not be effective at all" if doctors were made to prescribe only generic medicines,, according to pharma industry body IPA.
Also found in: [+]
IPA punches holes into drug pricing policy implementation 4.4.2017 ET: Pharma
"This is not a good sign. It is indicative of trust deficit in the regulatory mechanism and administrative machinery, be it the NPPA or CDSCO," it added.
Also found in: [+]
Union HRD Minister Prakash Javadekar Releases ‘India Rankings 2017’ 3.4.2017 Govt of india: PIB
The Union Minister of Human Resource Development, Shri Prakash Javadekar , released the India Rankings 2017 for the Educational Institutions and dedicated it to the nation in New Delhi today. Speaking on the occasion he said that this step is a sequel of our Government’s commitment towards bringing
Also found in: [+]
`India–EFTA trade talks may adversely impact access to medicines in developing countries' 23.3.2017 TOI: India
Also found in: [+]
Delhi HC dismisses Cipla's plea against single judge order 9.3.2017 ET: Pharma
The observation by the court came while dismissing Indian pharma company Cipla's bid to make and sell a generic version of Swiss drug major Novartis' patented respiratory disease medicine Indacaterol without a compulsory licence.
Also found in: [+]
Delhi High Court quashes Cipla's appeal, says it can't market generics of Novartis' Onbrez 9.3.2017 ET: Pharma
The court said it can't make a definitive conclusion that Novartis' imports of Onbrez were insufficient to meet the demands COPD patients from the data that was submitted by Cipla and Novartis during the hearings.
Also found in: [+]
Indian drug makers can export patented meds for approval: Delhi High Court 8.3.2017 ET: Pharma
Natco and Alembic, however, were directed to undertake that during the life of the respective patent, they will not export the respective patented invention for purposes other than those specified in section 107A.
Also found in: [+]
Delhi High Court favours Natco, Alembic; allows them to export generics of Bayer's drugs 8.3.2017 ET: Pharma
Bayer had approached court in 2016 to stop Alembic Pharmaceuticals from exporting its generic of the German company's blood thinner brand 'Xarelto' (Rivaroxaban), used to prevent and treat dangerous blood clots.
Also found in: [+]
Pharma lobby cries foul on GIPC’s poor ranking to India 3.3.2017 ET: Pharma
Global Intellectual Property Centre (GIPC) index on intellectual property (IP) standards once again places India at the bottom of 45 countries.
Also found in: [+]
BUZZ-India's Dr. Reddy's Labs hits over 1-year low; firm's drug infringes U.S. patents 16.2.2017 Sify Finance
** Shares of Dr Reddy's Laboratories fall as much as 3.9 pct, their lowest since Jan 22, 2016
Also found in: [+]
Healthcare and patient groups oppose patents on crucial hepatitis C drugs 15.2.2017 TOI: India
Also found in: [+]
NGOs strive to make hepatitis C drugs affordable 15.2.2017 TOI: India
Also found in: [+]
USTR urged not to demand excessive IP enforcement in India 14.2.2017 ET: Infotech
MSF said countries should not be penalised or discouraged from making use of the public health safeguards that are intended to protect access.
Also found in: [+]
US pharma sector demands keeping India in patent violator list 14.2.2017 ET: Pharma
PhRMA in a submission requested US Trade Representative (USTR) to continue to keep India on the Priority Watch List in the 2017 Special 301 Report.
Also found in: [+]
MNC pharma lobby pushes for single drug authority here 9.2.2017 ET: Pharma
The OPPI, which represents 22 pharma companies, including Abbott, Pfizer, Novartis, Novo Nordisk and Sanofi, also wants specialised patent courts for fast disposal of patents and IP disputes.
Also found in: [+]
Kerala tribe to get fiscal boost for sharing wonder energy plant 7.2.2017 DNA: Health
South India's Kani tribe, which discovered a life-promoting plant Arogyapacha, may now hold the patent to this valuable indigenous species
Also found in: [+]
US Court rules in favour of Mylan for Copaxone patents: Natco 31.1.2017 ET: Pharma
In December 2016, the US Patent and Trademark Office (PTO) had ruled in favour of Mylan and three patents related to Copaxone 40 mg/mL were found unpatentable.
Also found in: [+]
HC allows Indian firm to export drug in which Bayer has patent 29.1.2017 ET: Pharma
Bayer admitted before the court that it has not used its patents for commercial exploitation in India while Ajanta had launched its drug back in 2009-10 and was exporting it since then to various countries.
Also found in: [+]
1 to 20 of 2,776